Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
37,570,941
-
Share change
-
-1,846,071
-
Total reported value
-
$721,322,587
-
Put/Call ratio
-
92%
-
Price per share
-
$19.20
-
Number of holders
-
133
-
Value change
-
-$62,306,470
-
Number of buys
-
63
-
Number of sells
-
79
Institutional Holders of CLOVIS ONCOLOGY INC - COM (CLVSQ) as of Q1 2016
As of 31 Mar 2016,
CLOVIS ONCOLOGY INC - COM (CLVSQ) was held by
133 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
37,570,941 shares.
The largest 10 holders included
PointState Capital LP, Palo Alto Investors, LLC, Redmile Group, LLC, VANGUARD GROUP INC, HealthCor Management, L.P., Partner Fund Management, L.P., STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, and OppenheimerFunds, Inc..
This page lists
133
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.